IntegraMed America, Incorporation. : Law Office of Brodsky & Smith, LLC Announces Investigation of IntegraMed America, Inc.
06/13/2012| 06:35pm US/Eastern
Recommend:
Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of IntegraMed America,
Inc ("IntegraMed" or the "Company") (Nasdaq: INMD) relating to the
proposed acquisition by Sagard Capital Partners. ("Sagard").
Under the terms of the transaction, IntegraMed shareholders will receive
$14.05 in cash for each share of IntegraMed stock they own. The
investigation concerns possible breaches of fiduciary duty and other
violations of state law by the Board of Directors of IntegraMed for not
acting in the Company's shareholders' best interests in connection with
the sale process to Sagard. The transaction will not result in a
substantial premium above the $13.50 that IntegraMed stock traded at on
April 16, 2012 and is below a $17.00 analyst target price for IntegraMed
stock.
If you own shares of IntegraMed stock and wish to discuss the legal
ramifications of the proposed transaction, or have any questions, you
may e-mail or call the law office of Brodsky & Smith, LLC who will,
without obligation or cost to you, attempt to answer your questions. You
may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at
Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004,
by e-mail at investorrelations@brodsky-smith.com
visiting http://brodsky-smith.com/435-inmd-integramed-america-inc.html,
or by calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC
Jason L. Brodsky, Esquire
Evan J.
Smith, Esquire
877-LEGAL-90
investorrelations@brodsky-smith.com
http://brodsky-smith.com/435-inmd-integramed-america-inc.html
© Business Wire 2012
Recommend :
